Cargando…
Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction
BACKGROUND: More than 50% of the patients with heart failure have normal ejection fraction (HFNEF). Iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy and cardiopulmonary exercise test (CPET) are prognostic markers in HFNEF. Nebivolol is a beta-blocker with vasodilating properties. OBJECTIV...
Autores principales: | Messias, Leandro Rocha, Ferreira, Aryanne Guimarães, de Miranda, Sandra Marina Ribeiro, Teixeira, José Antônio Caldas, de Azevedo, Jader Cunha, Messias, Ana Carolina Nader Vasconcelos, Maróstica, Elisabeth, Mesquita, Claudio Tinoco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914000/ https://www.ncbi.nlm.nih.gov/pubmed/27096522 http://dx.doi.org/10.5935/abc.20160046 |
Ejemplares similares
-
Cardiac I123-MIBG Correlates Better than Ejection Fraction with Symptoms
Severity in Systolic Heart Failure
por: Miranda, Sandra M., et al.
Publicado: (2013) -
Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction
por: Park, Kyungil, et al.
Publicado: (2023) -
Heart Failure with Mid-Range Ejection Fraction - State of the
Art
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019) -
Nuclear Cardiology in 2020 - Perspectives of the New SBC Guideline
por: Mesquita, Cláudio Tinoco, et al.
Publicado: (2020) -
Systems Biology Applied to Heart Failure With Normal Ejection
Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2014)